Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.93 USD | +1.48% | +3.93% | -26.58% |
Apr. 20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
Apr. 20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.41M | Capitalization | 4.43B |
---|---|---|---|---|---|
Net income 2024 * | -250M | Net income 2025 * | -276M | EV / Sales 2024 * | - |
Net cash position 2024 * | 653M | Net cash position 2025 * | 532M | EV / Sales 2025 * | 270 x |
P/E ratio 2024 * |
-17.3
x | P/E ratio 2025 * |
-17
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.87% |
Latest transcript on Immunovant, Inc.
1 day | +1.48% | ||
1 week | +3.93% | ||
Current month | +12.72% | ||
1 month | +1.51% | ||
3 months | -18.17% | ||
6 months | -9.67% | ||
Current year | -26.58% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Salzmann
CEO | Chief Executive Officer | 56 | 19-05-31 |
Eva Barnett
DFI | Director of Finance/CFO | 44 | 21-10-03 |
Sheetal Patel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 19-12-17 |
Andrew Fromkin
BRD | Director/Board Member | 58 | 19-12-17 |
Douglas Hughes
BRD | Director/Board Member | 62 | 19-12-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.04% | 2 M€ | -.--% | ||
0.03% | 1,487 M€ | +8.31% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 30.93 | +1.48% | 854,549 |
24-05-14 | 30.48 | +2.01% | 828,173 |
24-05-13 | 29.88 | +1.67% | 594,123 |
24-05-10 | 29.39 | -1.04% | 1,272,466 |
24-05-09 | 29.7 | -0.20% | 655,555 |
Delayed Quote Nasdaq, May 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.58% | 4.43B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- IMVT Stock